Assignee
PTC THERAPEUTICS INC
US·126 granted patents·79 pending applications·1,260 citations·filing 1999–2025
Top patents by PatentIndex Score
205 records- 0199US7772259B21,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Aug 10, 2010·83 cites·33 claims
- 0299US7419991B23-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereofPTC THERAPEUTICS INC·Filed 2006·Granted Sep 2, 2008·70 cites·24 claims
- 0399US7304080B2Substituted 1,2,4-oxadiazoles, compositions and methods of usePTC THERAPEUTICS INC·Filed 2006·Granted Dec 4, 2007·55 cites·19 claims
- 0499US7202262B2Benzoic acid or benzoate substituted 1,2,4-oxadiazole compounds and their use for the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Apr 10, 2007·111 cites·19 claims
- 0599US6992096B21,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2004·Granted Jan 31, 2006·190 cites·7 claims
- 0698US8796322B2Methods for using 1,2,4-oxadiazole benzoic acid compoundsPTC THERAPEUTICS INC·Filed 2013·Granted Aug 5, 2014·21 cites·20 claims
- 0798US8017636B21,2,4-Oxadiazole benzoic acid compositions and their use in bioassaysPTC THERAPEUTICS INC·Filed 2010·Granted Sep 13, 2011·23 cites·4 claims
- 0898US7683082B21,2,4-oxadiazole benzoic acid compositions and their use in bioassaysPTC THERAPEUTICS INC·Filed 2007·Granted Mar 23, 2010·28 cites·4 claims
- 0997US9205088B2Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their usePTC THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·13 cites·21 claims
- 1097US8975287B2Methods for using 1,2,4-Oxadiazole benzoic acid compoundsPTC THERAPEUTICS INC·Filed 2014·Granted Mar 10, 2015·12 cites·16 claims
- 1196US7863456B2Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acidPTC THERAPEUTICS INC·Filed 2007·Granted Jan 4, 2011·29 cites·9 claims
- 1296US7767689B2Carboline derivatives useful in the treatment of cancerPTC THERAPEUTICS INC·Filed 2005·Granted Aug 3, 2010·40 cites·12 claims
- 1395US10071081B2Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their usePTC THERAPEUTICS INC·Filed 2017·Granted Sep 11, 2018·5 cites·18 claims
- 1495US9879007B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·18 cites·4 claims
- 1595US9873677B2Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acidPTC THERAPEUTICS INC·Filed 2015·Granted Jan 23, 2018·8 cites·21 claims
- 1695US9371336B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jun 21, 2016·36 cites·5 claims
- 1795US7601840B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2005·Granted Oct 13, 2009·39 cites·7 claims
- 1894US9861617B2Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their usePTC THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·4 cites·21 claims
- 1994US9617268B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Apr 11, 2017·32 cites·5 claims
- 2094US9586955B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Mar 7, 2017·22 cites·21 claims
- 2194US7678922B2Processes for the preparation of 1,2,4-oxadiazole benzoic acidsPTC THERAPEUTICS INC·Filed 2007·Granted Mar 16, 2010·31 cites·15 claims
- 2294US7405233B2Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Jul 29, 2008·27 cites·2 claims
- 2393US11304914B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2020·Granted Apr 19, 2022·2 cites·26 claims
- 2493US9399649B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jul 26, 2016·34 cites·11 claims
- 2593US7868037B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2006·Granted Jan 11, 2011·18 cites·31 claims
- 2692US11174212B22,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Nov 16, 2021·5 cites·32 claims
- 2792US9309206B2Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acidPTC THERAPEUTICS INC·Filed 2014·Granted Apr 12, 2016·9 cites·11 claims
- 2891US11186559B2Methods for enriching alpha-tocotrienol from mixed tocol compositionsPTC THERAPEUTICS INC·Filed 2020·Granted Nov 30, 2021·3 cites·23 claims
- 2991US10874672B2Methods for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2016·Granted Dec 29, 2020·13 cites·28 claims
- 3091US10703701B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2016·Granted Jul 7, 2020·7 cites·23 claims
- 3191US9522137B2Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2015·Granted Dec 20, 2016·8 cites·10 claims
- 3290US9877952B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2017·Granted Jan 30, 2018·6 cites·9 claims
- 3390US9737513B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·6 cites·9 claims
- 3490US7781478B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2007·Granted Aug 24, 2010·8 cites·7 claims
- 3589US11390588B22-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereofPTC THERAPEUTICS INC·Filed 2020·Granted Jul 19, 2022·2 cites·15 claims
- 3689US10981855B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2020·Granted Apr 20, 2021·2 cites·18 claims
- 3789US10517853B2Methods for treating epilepsyPTC THERAPEUTICS INC·Filed 2016·Granted Dec 31, 2019·9 cites·8 claims
- 3889US10034863B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·5 cites·8 claims
- 3989US9474743B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2014·Granted Oct 25, 2016·8 cites·15 claims
- 4089US9394539B1Survival motor neuron gene (SMN2) mRNA constructs for post-transcription regulationPTC THERAPEUTICS INC·Filed 2012·Granted Jul 19, 2016·14 cites·20 claims
- 4189US8372860B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2010·Granted Feb 12, 2013·12 cites·21 claims
- 4289US8367694B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2009·Granted Feb 5, 2013·12 cites·23 claims
- 4389US7772271B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2007·Granted Aug 10, 2010·8 cites·7 claims
- 4488US11667596B22,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·1 cites·19 claims
- 4588US10751302B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·2 cites·20 claims
- 4688US10172836B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapyPTC THERAPEUTICS INC·Filed 2018·Granted Jan 8, 2019·4 cites·9 claims
- 4788US8367841B2Processes for the preparation of 1,2,4-oxadiazole benzoic acidsPTC THERAPEUTICS INC·Filed 2009·Granted Feb 5, 2013·10 cites·8 claims
- 4888US7645881B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2005·Granted Jan 12, 2010·5 cites·12 claims
- 4987US10195202B2Methods for modulating the amount of RNA transcriptsPTC THERAPEUTICS INC·Filed 2014·Granted Feb 5, 2019·4 cites·8 claims
- 5087US10028939B2Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of diseasePTC THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·3 cites·18 claims
Showing the top 50 of 205 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PTC THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →